Sfoglia per Autore
Contribution of dendritic cells FcgammaRI and FcgammaRIII to cross-presentation of tumor cells opsonized with the anti-MHC class I monoclonal antibodies
2007-01-01 SIGNORINO E; BRUSA D; GRANATA R; MALAVASI F; FERRONE S; MATERA L
Apoptic renal carcinoma cells are better inducers of cross-presenting activity than their primary necrotic counterpart
2007-01-01 D' Hooghe E; Buttiglieri S; Bisignano G; Brusa D; Camussi G; Matera L
Post-apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross-presentation activity
2008-01-01 Brusa D; Garetto S; Chiorino G; Scatolini M; Migliore E; Camussi G; Matera L
Correlation between NK function and response to trastuzumab in metastatic breast cancer patients
2008-01-01 Beano A; Signorino E; Evangelista A; Brusa D; Mistrangelo M; Polimeni MA; Spadi R; Donadio M; Ciuffreda L; Matera L.
Binding of prostate-specific membrane antigen to dendritic cells: a critical step in vaccine preparation
2009-01-01 Garetto S; Sizzano F; Brusa D; Tizzani A; Malavasi F; Matera L.
iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells
2009-01-01 De Boo S; Kopecka J; Brusa D; Gazzano E; Matera L; Ghigo D; Bosia A; Riganti C.
Immunogenicity of 56 degrees C and UVC-treated prostate cancer is associated with release of HSP70 and HMGB1 from necrotic cells
2009-01-01 BRUSA D; MIGLIORE E; GARETTO S; SIMONE M; MATERA L
CD73-Generated Extracellular Adenosine Creates Microenvironmental Conditions Favoring Growth and Survival of Chronic Lymphocytic Leukemia Cells
2011-01-01 Sara Serra; Alberto Horenstein; Tiziana Vaisitti; Davide Brusa; Davide Rossi; Luca Laurenti; Giovanni D'Arena; Marta Coscia; Claudio Tripodo; Giorgio Inghirami; Simon Robson; Gianluca Gaidano; Fabio Malavasi; Silvia Deaglio
NAD+-metabolizing ecto-enzymes shape tumor-host interactions: the chronic lymphocytic leukemia model.
2011-01-01 Vaisitti T; Audrito V; Serra S; Bologna C; Brusa D; Malavasi F; Deaglio S
Prostatectomy restores the maturation competence of blood dendritic cell precursors and reverses the abnormal expansion of regulatory T lymphocytes.
2011-01-01 Brusa D; Carletto S; Cucchiarale G; Gontero P; Greco A; Simone M; Ferrando U; Tizzani A; Matera L.
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death
2011-01-01 Serra S; Horenstein AL; Vaisitti T; Brusa D; Rossi D; Laurenti L; D'Arena G; Coscia M; Tripodo C; Inghirami G; Robson SC; Gaidano G; Malavasi F; Deaglio S.
Nitric oxide and P-glycoprotein modulate the phagocytosis of colon cancer cells
2011-01-01 Kopecka J; Campia I; Brusa D; Doublier S; Matera L; Ghigo D; Bosia A; Riganti C
THE PD-1/PD-L1 AXIS CONTRIBUTES TO T CELL DYSFUNCTION IN CHRONIC LYMPHOCYTIC LEUKEMIA
2012-01-01 Brusa D; Serra S; Bianco M; Coscia M; Rossi D; Gaidano G; Fedele G; Deaglio S
SLAMF1/CD150 IS A SIGNALING RECEPTOR EXPRESSED BY A SUBSET OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS CHARACTERIZED BY A FAVORABLE PROGNOSIS
2012-01-01 Bologna C; Buonincontri R; Serra S; Vaisitti T; Audrito V; Brusa D; Rossi D; Coscia M; Gaidano G; Terhorst C; Deaglio S
Slamf-1/CD150 Is a Signaling Receptor Expressed by a Subset of Chronic Lymphocytic Leukemia Patients Characterized by a Favorable Prognosis
2012-01-01 Cinzia Bologna; Roberta Buonincontri; Sara Serra; Tiziana Vaisitti; Valentina Audrito; Davide Brusa; Davide Rossi; Marta Coscia; Gianluca Gaidano; Cox Terhorst; Silvia Deaglio
The PD-1/PD-L1 Axis Contributes to T Cell Dysfunction in Chronic Lymphocytic Leukemia
2012-01-01 Davide Brusa; Sara Serra; Marta Coscia; Davide Rossi; Gianluca Gaidano; Giorgio Inghirami; Tiziana Vaisitti; Silvia Deaglio
The PD-1/PD-L1 axis contributes to T cell dysfunction in chronic lymphocytic leukemia
2012-01-01 Brusa, D; Serra, S; Bianco, M; Coscia, M; Rossi, D; Gaidano, G; Fedele, G; Deaglio, S
Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: Profile comparison.
2013-01-01 Brusa D; Simone M; Gontero P; Spadi R; Racca P; Micari J; Degiuli M; Carletto S; Tizzani A; Matera L
Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia.
2013-01-01 Vaisitti T; Audrito V; Serra S; Bologna C; Arruga F; Brusa D; Buonincontri R; Gizdic B; Deaglio S.
Targeting the microenvironment in chronic lymphocytic leukemia offers novel therapeutic options.
2013-01-01 Audrito V; Vaisitti T; Serra S; Bologna C; Brusa D; Malavasi F; Deaglio S.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile